Lung Cancer and Pleural Mesothelioma

  • Robert G. Parker
  • Nora A. Janjan
  • Michael T. Selch
Part of the Medical Radiology book series (MEDRAD)

Abstract

Carcinomas arising in the lung are the most common noncutaneous cancers in humans in the United States. In the year 2001, the estimated number of new diagnoses of lung cancer in this country was 169,500 (55% in men, 45% in women) [1]. These tumors constituted about 14% of the cancer incidence (men, 15%; women, 13%) and 28% of the cancer-related mortality (men, 32%; women, 28%) exclusive of skin cancers and carcinoma in situ of the cervix [2]. Lung cancer has been increasing in women and now exceeds breast cancer in the frequency of cancer-related mortality.

Keywords

Fatigue Adenocarcinoma Dementia Tuberculosis Radioactive Isotope 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Greenlee RT, Murray T, Bolden S, Wingo PA (2000) Cancer statistics 2000. CA Cancer J Clin 50: 7–33PubMedCrossRefGoogle Scholar
  2. 2.
    Figlin RA, Cameron RB, Turrisi AT III (2001) Non small cell lung cancer. In: Haskell CM (ed) Cancer treatment, 5th edn. Saunders, Philadelphia, pp 598–628Google Scholar
  3. 3.
    Travis WD, Colby TV, Corrin B et al (1999) World Health Organization Pathology Panel: World Health Organization. Histological typing of lung and pleural tumors. International histological classification of tumors, 3rd edn. Springer, Berlin Heidelberg New YorkGoogle Scholar
  4. 4.
    Paulsen DL (1971) Superior sulcus tumors: results of combined therapy. N Y State J Med 71: 2050–2057Google Scholar
  5. 5.
    Lassen U, Hansen HH (2001) Small cell carcinoma of the lung. In: Haskell CM (ed) Cancer treatment, 5th edn. Saunders, Philadelphia, pp 629–639Google Scholar
  6. 6.
    Hirsch FR, Osterlind K, Hanssen HH (1983) The prognostic significance of histopathologic subtyping of small cell carcinoma of the lung according to the classification of the World Health Organization. Cancer 52: 2144–2150PubMedCrossRefGoogle Scholar
  7. 7.
    Line DH, Deeley TJ (1971) The necropsy findings in carcinoma of the bronchus. Br J Dis Chest 65: 238–242PubMedCrossRefGoogle Scholar
  8. 8.
    Emami B, Graham MV (1998) Lung. In: Perez CA, Brady LW (eds) Principles and practice of radiation oncology, 3rd edn. Lippincott-Raven, Philadelphia, pp 1181–1220Google Scholar
  9. 9.
    Gray H (1995) Gray’s anatomy: the anatomical basis of medicine and surgery. Churchill-Livingstone, New YorkGoogle Scholar
  10. 10.
    Nagaishi C (1972) Functional anatomy and histology of the lung. University Park Press, BaltimoreGoogle Scholar
  11. 11.
    Nathanson L, Hall T (1974) A spectrum of tumors that produce paraneoplastic syndromes: lung tumors. How they produce their syndromes. Ann N Y Acad Sci 230: 367–377PubMedCrossRefGoogle Scholar
  12. 12.
    Scott W, Schwabe J, Gupta N et al (1994) Positron emission tomography of lung tumors and mediastinal lymph nodes using ‘8F-fluorodeoxyglucose. Ann Thorac Surg 58: 698–703PubMedCrossRefGoogle Scholar
  13. 13.
    Erozan Y, Frost J (1974) Cystopathological diagnosis of lung cancer. Semin Oncol 1: 191–198PubMedGoogle Scholar
  14. 14.
    Doale P, Bode F, Kini S (1976) Diagnostic accuracy in lung cancer: comparison of techniques used in association with flexible fiberoptic bronchoscopy. Chest 69: 752–757CrossRefGoogle Scholar
  15. 15.
    Richardson R, Zavala D, Jukerjee P (1974) The use of fiber-optic bronchoscopy and brush biopsy in the diagnosis of suspected pulmonary malignancy. Am Rev Respir Dis 109: 63–66PubMedGoogle Scholar
  16. 16.
    Sagel S, Ferguson T, Forrest J (1978) Percutaneous trans-thoracic aspiration needle biopsy. Ann Thorac Surg 26: 399–405PubMedCrossRefGoogle Scholar
  17. 17.
    Skinner W (1979) Pulmonary neoplasms diagnosed with transthoracic needle biopsy. Cancer 43: 1533–1540CrossRefGoogle Scholar
  18. 18.
    Grover F (1994) The role of CT and MRI in staging of the mediastinum. Chest 106: 3918–3968CrossRefGoogle Scholar
  19. 19.
    Thomas P (1994) The role of mediastinal staging of lung cancer. Chest 106: 331S - 333SPubMedGoogle Scholar
  20. 20.
    Mountain CF, Carr D, Anderson W (1974) A system for the clinical staging of lung cancer. Am J Roentgenol 120: 130–138CrossRefGoogle Scholar
  21. 21.
    Mountain CF (1989) A new international staging system for lung cancer. Chest 89 [Suppl]: 225S - 2395Google Scholar
  22. 22.
    Mountain C (1997) Revisions in the International System for Staging Lung Cancer. Chest 111: 1710–1717PubMedCrossRefGoogle Scholar
  23. 23.
    Mountain C, Dresler C (1997) Regional lymph node classification for lung cancer staging. Chest 111: 1718–1723PubMedCrossRefGoogle Scholar
  24. 24.
    Curran WJ Jr (2001) Small cell lung cancer. In: Gunderson LL, Tepper JE (eds) Clinical radiation oncology, 1st edn. Churchill Livingstone, EdinburghGoogle Scholar
  25. 25.
    Green RA, Humphrey E, Close H et al (1969) Alkylating agents in bronchogenic carcinoma. Am J Med 49: 360–367Google Scholar
  26. 26.
    Eaton W, Maurer H, Glicksman A et al (1981) The relationship of infield recurrences to prescribed tumor dose in small cell carcinoma of the lung (abstract). Int J Radiat Oncol Biol Phys 7: 1223CrossRefGoogle Scholar
  27. 27.
    White J, Chen R, McCracken Jet al (1982) The influence of radiation therapy quality control on survival, response and sites of relapse in oat cell carcinoma of the lung. Preliminary report of a SWOG study. Cancer 50: 1084–1090Google Scholar
  28. 28.
    Kies MS, Mira JG, Crowley JJ et al (1987) Multimodal therapy for limited small cell lung cancer: a randomized study of induction combination chemotherapy with or without thoracic radiation in complete responders and with wide-field versus reduced-field radiation in partial responders. A Southwest Oncology Group Study. J Clin Oncol 5: 592–600Google Scholar
  29. 29.
    Liengswangwong V, Bonner JA, Shaw EG et al (1994) Limited-stage small cell lung cancer: patterns of intrathoracic recurrence and the implications for thoracic radiotherapy. J Clin Oncol 12: 496–502PubMedGoogle Scholar
  30. 30.
    Arriagada R, LeCakvalier T, Borie F et al (1995) Prophylactic cranial irradiation for patients with small lung cancer in complete remission. J Natl Cancer Inst 87: 183–190PubMedCrossRefGoogle Scholar
  31. 31.
    Gregor A, Cull A, Stephens RJ et al (1995) Effects of prophylactic irradiation for patients with small cell lung cancer in complete response (abstract). Eur J Cancer 31A: S19CrossRefGoogle Scholar
  32. 32.
    Arriagada R, Duperin A, Pignon JP et al (1998) Prophylactic cranial irradiation in patients with small cell lung cancer in complete remission (abstract). Proc Am Soc Clin Oncol 17: 457Google Scholar
  33. 33.
    Ginsberg R, Rubinstein L (1983) Randomized trial of lobectomy versus limited resection for T1 No non-small cell lung cancer. J Thorac Cardiovasc Surg 86: 654–658PubMedGoogle Scholar
  34. 34.
    Wagner H Jr (2001) Non-small cell lung cancer. In: Gunderson LL, Tepper JE (eds) Clinical radiation oncology, 1st edn. Churchill Livingstone, Edinburgh, pp 600–629Google Scholar
  35. 35.
    Dillman RO, Seagreen SL, Herdon J, Green MR (1993) Randomized trial of induction chemotherapy plus radiation therapy vs RT alone in Stage III non small cell lung cancer (NSCLC): five-year follow-up of CALGB. Proc ASCO 12: 329Google Scholar
  36. 36.
    Le Chevalier T, Arriagada R, Tarayre M et al (1992) Significant effect of adjuvant chemotherapy on survival in locally advanced non-small cell lung carcinoma. J Natl Cancer Inst 84: 58PubMedCrossRefGoogle Scholar
  37. 37.
    Mira JG, Miller TP, Crowley JJ (1990) Chest irradiation (RT) vs chest RT + chemotherapy + prophylactic brain RT in localized non small cell lung cancer: a SWOG randomized study. Int J Radiat Oncol Biol Phys 19 [Suppl]: 145CrossRefGoogle Scholar
  38. 38.
    Morton RF, Jett JR, McGinnis WL et al (1991) Thoracic radiation therapy alone compared with combined chemotherapy for locally unresectable non small cell lung cancer: a randomized, phase III trial. Ann Intern Med 115: 681–686PubMedCrossRefGoogle Scholar
  39. 39.
    Schaake-Koning C, van den Bogaert W, Dalesio O et al (1992) Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer. N Engl J Med 326: 524–530PubMedCrossRefGoogle Scholar
  40. 40.
    Ansari R, Tohar SR, Fisher W et al (1991) A phase III study of thoracic irradiation with or without concomitant cisplatin in loco-regional unresectable non small cell lung cancer (NSCLC): a Hoosier Oncology Group protocol. Am Soc Clin Oncol 10: 241–243Google Scholar
  41. 41.
    Trovo MG, Minatel E, Veronesi A et al (1990) Combined radiotherapy and chemotherapy versus radiotherapy alone in locally advanced epidermoid bronchogenic carcinoma: a randomized study. Cancer 65: 400–404PubMedCrossRefGoogle Scholar
  42. 42.
    Lutz ST, Hwang DT, Ferguson C et al (1997) A retrospective quality of life analysis using the lung cancer symptom scale in patients treated with palliative radiotherapy for advanced non-scale cell lung cancer. Int J Radiat Oncol Biol Phys 37 (1): 117–122PubMedCrossRefGoogle Scholar
  43. 43.
    Teo P, Tai TH, Choy D, Tsui KH (1988) A randomized study on palliative radiation therapy for inoperable non-small cell carcinoma of the lung. Int J Radiat Oncol Biol Phys 14: 867–871PubMedCrossRefGoogle Scholar
  44. 44.
    Wagner H Jr. Non-small cell lung cancer, Chpt 32 in Clinical Radiation Oncology. Gunderson LL, Tepper JE (eds), Churchill Livingstone, 1st edn. 2000, pp 600–629Google Scholar
  45. 45.
    Komaki R, Cox JD. The Lung and Thymus, Chpt 14 in Moss: Radiation Oncology: Rationale, Technique, Results ed Cox JD Modby 7th edn. 1994, pp 320–351Google Scholar
  46. 46.
    Loeffler JS, Patchell RA, Saway AR. Metastatic brain cancer from Cancer: Principles and Practice of Oncology, 5th edn., De Vita V Jr, Hellman S, Rosenberg SA (eds) Lippincott-Raven Publishers, Philadelphia 1997, pp 2523–2536Google Scholar
  47. 47.
    Stoll BA. Natural history, prognosis and staging of bone metastases, in Stoll BA, Parboo S (eds). Bone Metastases Monitoring and Treatment. New York, NY. Raven 1983, pp 1–20Google Scholar
  48. 48.
    Sculier JP, Feld R (1985) Superior vena cava obstruction syndrome: Recommendations and management. Cancer Treat Rev 12 (3): 210–218CrossRefGoogle Scholar
  49. 49.
    Yohalom J. Superior vena cava syndrome, in Cancer: Principles and Practice of Oncology, 5th edn., De Vita VT Jr, Hellman S, Rosenberg SA, Lippincott-Raven Publishers, Philadelphia 1997, pp 2469–2476Google Scholar
  50. 50.
    Langendijk JA, Ten Velde GPM, Aaronson NK et al (2000) Quality of life after palliative radiotherapy in non-small cell lung cancer. Int J Radiat Oncol Biol Phys 47 (1): 149–155PubMedCrossRefGoogle Scholar
  51. 51.
    Simpson R, Francis ME, Perez-Tamayo R et al (1985) Palliative radiotherapy for inoperable carcinoma of the lung: Final report of a RTOG multi-institutional trial. Int J Radiat Oncol Biol Phys 11: 751–758Google Scholar
  52. 52.
    Bleehen NM, Girling FJ, Macking D, Stephens RJ (1992) A medical research council (MRC) randomized trial of palliative radiotherapy with two fractions or a single fraction in patients with inoperable non-small cell lung cancer ( NSCLC) and poor performance status. Br J Cancer 65: 934–941Google Scholar
  53. 53.
    Langendijk JA, Aaronson JMA, deJong GPM et al (2001) Prospective study on quality od life before and after radical radiotherapy in non-small cell lung cancer. Jrn Clin Oncol 19 (8): 2123–2133Google Scholar
  54. 54.
    NCCN Practice Guidelines for Cancer-Related Fatigue. Version 2000. Oncology 14 (11A): 151–161Google Scholar
  55. 55.
    Reddy SP, Marks JE (1990) Total acelectasis of the lung secondary to malignant airway obstruction. Am J Clin Oncol 13 (5): 394–400PubMedCrossRefGoogle Scholar
  56. 56.
    Kelly JF, Delclos ME, Morice RC et al. High dose-rate endobronchial brachytherapy effectively palliates symptoms due to airway tumors: The 10-year MD Anderson Cancer Center ExperienceGoogle Scholar
  57. 57.
    Chetty KG, Moran EM, Sassoon CSH et al (1989) Effect of radiation therapy on bronchial obstruction due to bronchogenic carcinoma. Chest 96 (3): 582–584CrossRefGoogle Scholar
  58. 58.
    Majid OA, Lee S, Khushalani S, Seydel HG (1986) The response of atelectsiss from lung cancer to radiation therapy. Int J Radiat Oncol Biol Phys 12: 231–232PubMedCrossRefGoogle Scholar
  59. 59.
    Chang L-FL, Horvath J, Peyton W, Lang S-S (1994) High dose rate afterloading intraluminal Brachytherapy in malignant airway obstruction of lung cancer. int J Radiat Oncol Biol Phys 28 (3): 589–596CrossRefGoogle Scholar
  60. 60.
    Mehta M, Petereit D, Chosy L et al (1992) Sequential comparison of low dose rate and hyperfractionated high dose rate endobronchial radiation for malignant airway obstruction. Int J Radiat Oncol Biol Phys 23: 133–139PubMedCrossRefGoogle Scholar
  61. 61.
    Raju PI, Roy T, McDonald RD et al (1993) Ir-192 low dose rate endobronchial brachytherapy in the treatment of malignant airway obstruction. Int J Radiat Oncol Biol Phys 27: 677–680PubMedCrossRefGoogle Scholar
  62. 62.
    Spieser B, Spratling L (1990) intermediate dose rate remote afterloading brachytherapy for intraluminal control of bronchogenic carcinoma. Int J Radiat Oncol Biol Phys 18: 1443–1448Google Scholar
  63. 1.
    Greenlee RT, Murray T, Bolden S, Wingo PA (2000) Cancer 24. statistics 2000. CA Cancer J Clin 50: 7–33PubMedCrossRefGoogle Scholar
  64. 2.
    Figlin RA, Cameron RB, Turrisi AT III (2001) Non small cell lung cancer. In: Haskell CM (ed) Cancer treatment, 25. 5th edn. Saunders, Philadelphia, pp 598–628Google Scholar
  65. 3.
    Travis WD, Colby TV, Corrin B et al (1999) World Health Organization Pathology Panel: World Health Organiza- 26. tion. Histological typing of lung and pleural tumors. International histological classification of tumors, 3rd edn. Springer, Berlin Heidelberg New YorkGoogle Scholar
  66. 4.
    Paulsen DL (1971) Superior sulcus tumors: results of 27. combined therapy. N Y State J Med 71: 2050–2057Google Scholar
  67. 5.
    Lassen U, Hansen HH (2001) Small cell carcinoma of the lung. In: Haskell CM (ed) Cancer treatment, 5th edn. Saunders, Philadelphia, pp 629–639 28.Google Scholar
  68. 6.
    Hirsch FR, Osterlind K, Hanssen HH (1983) The prognostic significance of histopathologic subtyping of small cell carcinoma of the lung according to the classification of the World Health Organization. Cancer 52: 2144–2150PubMedCrossRefGoogle Scholar
  69. 7.
    Line DH, Deeley TJ (1971) The necropsy findings in carcinoma of the bronchus. Br J Dis Chest 65: 238–242PubMedCrossRefGoogle Scholar
  70. 8.
    Emami B, Graham MV (1998) Lung. In: Perez CA, Brady 29. LW (eds) Principles and practice of radiation oncology, 3rd edn. Lippincott-Raven, Philadelphia, pp 1181–1220Google Scholar
  71. 9.
    Gray H (1995) Gray’s anatomy: the anatomical basis of medicine and surgery. Churchill-Livingstone, New York 30.Google Scholar
  72. 10.
    Nagaishi C (1972) Functional anatomy and histology of the lung. University Park Press, BaltimoreGoogle Scholar
  73. 11.
    Nathanson L, Hall T (1974) A spectrum of tumors that 31. produce paraneoplastic syndromes: lung tumors. How they produce their syndromes. Ann N Y Acad Sci 230: 367–377 32.Google Scholar
  74. 12.
    Scott W, Schwabe J, Gupta N et al (1994) Positron emission tomography of lung tumors and mediastinal lymph nodes using 18F-fluorodeoxyglucose. Ann Thorac Surg 58: 698–703 33.Google Scholar
  75. 13.
    Erozan Y, Frost J (1974) Cystopathological diagnosis of lung cancer. Semin Oncol 1: 191–198PubMedGoogle Scholar
  76. 14.
    Doale P, Bode F, Kini S (1976) Diagnostic accuracy in lung 34. cancer: comparison of techniques used in association with flexible fiberoptic bronchoscopy. Chest 69: 752–757CrossRefGoogle Scholar
  77. 15.
    Richardson R, Zavala D, Jukerjee P (1974) The use of fiber-optic bronchoscopy and brush biopsy in the diagnosis of 35. suspected pulmonary malignancy. Am Rev Respir Dis 109: 63–66PubMedGoogle Scholar
  78. 16.
    Sagel S, Ferguson T, Forrest J (1978) Percutaneous trans-thoracic aspiration needle biopsy. Ann Thorac Surg 26: 399–405 36.Google Scholar
  79. 17.
    Skinner W (1979) Pulmonary neoplasms diagnosed with transthoracic needle biopsy. Cancer 43: 1533–1540CrossRefGoogle Scholar
  80. 18.
    Grover F (1994) The role of CT and MRI in staging of the mediastinum. Chest 106: 3918–3968 37.Google Scholar
  81. 19.
    Thomas P (1994) The role of mediastinal staging of lung cancer. Chest 106: 331S - 333SPubMedGoogle Scholar
  82. 20.
    Mountain CF, Carr D, Anderson W (1974) A system for the clinical staging of lung cancer. Am J Roentgenol 120: 130–138 38.Google Scholar
  83. 21.
    Mountain CF (1989) A new international staging system for lung cancer. Chest 89 [Suppl]: 2255–239SGoogle Scholar
  84. 22.
    Mountain C (1997) Revisions in the International System for Staging Lung Cancer. Chest 111: 1710–1717PubMedCrossRefGoogle Scholar
  85. 23.
    Mountain C, Dresler C (1997) Regional lymph node classification for lung cancer staging. Chest 111: 1718–1723PubMedCrossRefGoogle Scholar
  86. 24.
    Curran WJ Jr (2001) Small cell lung cancer. In: Gunderson LL, Tepper JE (eds) Clinical radiation oncology, 1st edn. Churchill Livingstone, EdinburghGoogle Scholar
  87. 25.
    Green RA, Humphrey E, Close H et al (1969) Alkylating agents in bronchogenic carcinoma. Am J Med 49: 360–367Google Scholar
  88. 26.
    Eaton W, Maurer H, Glicksman A et al (1981) The relationship of infield recurrences to prescribed tumor dose in small cell carcinoma of the lung (abstract). Int J Radiat Oncol Biol Phys 7: 1223CrossRefGoogle Scholar
  89. 27.
    White J, Chen R, McCracken J et al (1982) The influence of radiation therapy quality control on survival, response and sites of relapse in oat cell carcinoma of the lung. Preliminary report of a SWOG study. Cancer 50: 1084–1090Google Scholar
  90. 28.
    Kies MS, Mira JG, Crowley JJ et al (1987) Multimodal therapy for limited small cell lung cancer: a randomized study of induction combination chemotherapy with or without thoracic radiation in complete responders and with wide-field versus reduced-field radiation in partial responders. A Southwest Oncology Group Study. J Clin Oncol 5: 592–600Google Scholar
  91. 29.
    Liengswangwong V, Bonner JA, Shaw EG et al (1994) Limited-stage small cell lung cancer: patterns of intrathoracic recurrence and the implications for thoracic radiotherapy. J Clin Oricol 12: 496–502Google Scholar
  92. 30.
    rriagada R, LeCakvalier T, Borie F et al (1995) Prophylactic cranial irradiation for patients with small lung cancer in complete remission. J Natl Cancer Inst 87: 183–190CrossRefGoogle Scholar
  93. 31.
    Gregor A, Cull A, Stephens RJ et al (1995) Effects of prophylactic irradiation for patients with small cell lung cancer in complete response (abstract). Eur J Cancer 31A: S19CrossRefGoogle Scholar
  94. 32.
    Arriagada R, Duperin A, Pignon JP et al (1998) Prophylactic cranial irradiation in patients with small cell lung cancer in complete remission (abstract). Proc Am Soc Clin Oncol 17: 457Google Scholar
  95. 33.
    Ginsberg R, Rubinstein L (1983) Randomized trial of lobectomy versus limited resection for T1 No non-small cell lung cancer. J Thorac Cardiovasc Surg 86: 654–658PubMedGoogle Scholar
  96. 34.
    Wagner H Jr (2001) Non-small cell lung cancer. In: Gunderson LL, Tepper JE (eds) Clinical radiation oncology, 1st edn. Churchill Livingstone, Edinburgh, pp 600–629Google Scholar
  97. 35.
    Dillman RO, Seagreen SL, Herdon J, Green MR (1993) Randomized trial of induction chemotherapy plus radiation therapy vs RT alone in Stage III non small cell lung cancer (NSCLC): five-year follow-up of CALGB. Proc ASCO 12: 329Google Scholar
  98. 36.
    Le Chevalier T, Arriagada R, Tarayre M et al (1992) Significant effect of adjuvant chemotherapy on survival in locally advanced non-small cell lung carcinoma. J Natl Cancer Inst 84: 58PubMedCrossRefGoogle Scholar
  99. 37.
    Mira JG, Miller TP, Crowley JJ (1990) Chest irradiation (RT) vs chest RT + chemotherapy + prophylactic brain RT in localized non small cell lung cancer: a SWOG randomized study (abstract). Int J Radiat Oncol Biol Phys 19 [Suppl]: 145CrossRefGoogle Scholar
  100. 38.
    Morton RF, Jett JR, McGinnis WL et al (1991) Thoracic radiation therapy alone compared with combined chemotherapy for locally unresectable non small cell lung cancer: a randomized, phase III trial. Ann Intern Med 115: 681–686PubMedCrossRefGoogle Scholar
  101. 39.
    Schaake-Koning C, van den Bogaert W, Dalesio O et al (1992) Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer. N Engl J Med 326: 524–530PubMedCrossRefGoogle Scholar
  102. 40.
    Ansari R, Tohar SR, Fisher W et al (1991) A phase III study of thoracic irradiation with or without concomitant cisplatin in loco-regional unresectable non small cell lung cancer (NSCLC): a Hoosier Oncology Group protocol. Am Soc Clin Oncol 10: 241Google Scholar
  103. 41.
    Trovo MG, Minatel E, Veronesi A et al (1990) Combined radiotherapy and chemotherapy versus radiotherapy alone in locally advanced epidermoid bronchogenic carcinoma: a randomized study. Cancer 65: 400–404PubMedCrossRefGoogle Scholar
  104. 42.
    Lutz ST, Hwang DT, Ferguson C et al (1997) A retrospective quality of life analysis using the lung cancer symptom scale in patients treated with palliative radiotherapy for advanced non-small cell lung cancer. Int J Radiat Oncol Biol Phys 37: 117–122PubMedCrossRefGoogle Scholar
  105. 43.
    Teo P, Tai TH, Choy D, Tsui KH (1988) A randomized study on palliative radiation therapy for inoperable non-small cell carcinoma of the lung. Int J Radiat Oncol Biol Phys 14: 867–871PubMedCrossRefGoogle Scholar
  106. 44.
    Wagner H Jr (2000) Non-small cell lung cancer. In: Gunderson LL, Tepper JE (eds) Clinical radiation oncology, 1st edn. Churchill Livingstone, Edinburgh, pp 600629Google Scholar
  107. 45.
    Komaki R, Cox JD (1994) The lung and thymus. In: Cox JD (ed) Moss’ radiation oncology: rationale, technique, results, 7th edn. Mosby, St. Louis, pp 320–351Google Scholar
  108. 46.
    Loeffler JS, Patchell RA, Saway AR (1997) Metastatic brain cancer. In: DeVita V Jr, Hellman S, Rosenberg SA (eds) Cancer: principles and practice of oncology, 5th edn. Lippincott-Raven, Philadelphia, pp 2523–2536Google Scholar
  109. 47.
    Stoll BA (1983) Natural history, prognosis and staging of bone metastases. In: Stoll BA, Parboo S (eds) Bone metastases monitoring and treatment. Raven, New York, pp 1–20Google Scholar
  110. 48.
    Sculier JP, Feld R (1985) Superior vena cava obstruction syndrome: recommendations and management. Cancer Treat Rev 12: 210–218Google Scholar
  111. 49.
    Ychalom J (1997) Superior vena cava syndrome. In: DeVita VT Jr, Hellman S, Rosenberg SA (eds) Cancer: principles and practice of oncology, 5th edn. Lippincott-Raven, Philadelphia, pp 2469–2476Google Scholar
  112. 50.
    Langendijk JA, Ten Velde GPM, Aaronson NK et al (2000) Quality of life after palliative radiotherapy in non-small cell lung cancer. Int J Radiat Oncol Biol Phys 47: 149–155PubMedCrossRefGoogle Scholar
  113. 51.
    Simpson R, Francis ME, Perez-Tamayo R et al (1985) Palliative radiotherapy for inoperable carcinoma of the lung: final report of a RTOG multi-institutional trial. Int J Radiat Oncol Biol Phys 11: 751–758PubMedCrossRefGoogle Scholar
  114. 52.
    Bleehen NM, Girling FJ, Mackin D, Stephens RJ (1992) A medical research council (MRC) randomized trial of palliative radiotherapy with two fractions or a single fraction in patients with inoperable non-small cell lung cancer ( NSCLC) and poor performance status. Br J Cancer 65: 934–941Google Scholar
  115. 53.
    Langendijk JA, Aaronson JMA, de Jong GPM et al (2001) Prospective study on quality of life before and after radical radiotherapy in non-small cell lung cancer. J Clin Oncol 19: 2123–2133PubMedGoogle Scholar
  116. 54.
    NCCN Practice Guidelines for Cancer-Related Fatigue (2000) Version 2000. Oncology 14: 151–161Google Scholar
  117. 55.
    Reddy SP, Marks JE (1990) Total atelectasis of the lung secondary to malignant airway obstruction. Am J Clin Oncol 13: 394–400PubMedCrossRefGoogle Scholar
  118. 56.
    Kelly JF, Delclos ME, Morice RC et al High dose-rate endobronchial brachytherapy effectively palliates symptoms due to airway tumors: the 10-year MD Anderson Cancer Center Experience. Int J Radiat Oncol Biol Phys 48: 697–702Google Scholar
  119. 57.
    Chetty KG, Moran EM, Sassoon CSH et al (1989) Effect of radiation therapy on bronchial obstruction due to bronchogenic carcinoma. Chest 96: 582–584CrossRefGoogle Scholar
  120. 58.
    Majid OA, Lee S, Khushalani S, Seydel HG (1986) The response of atelectasis from lung cancer to radiation therapy. Int J Radiat Oncol Biol Phys 12: 231–232PubMedCrossRefGoogle Scholar
  121. 59.
    Chang L-FL, Horvath J, Peyton W, Lang S-S (1994) High dose rate afterloading intraluminal brachytherapy in malignant airway obstruction of lung cancer. Int J Radiat Oncol Biol Phys 28: 589–596PubMedCrossRefGoogle Scholar
  122. 60.
    Mehta M, Petereit D, Chosy L et al (1992) Sequential comparison of low dose rate and hyperfractionated high dose rate endobronchial radiation for malignant airway obstruction. Int J Radiat Oncol Biol Phys 23: 133–139PubMedCrossRefGoogle Scholar
  123. 61.
    Raju PI, Roy T, McDonald RD et al (1993) Ir-192 low dose rate endobronchial brachytherapy in the treatment of malignant airway obstruction. Int J Radiat Oncol Biol Phys 27: 677–680PubMedCrossRefGoogle Scholar
  124. 62.
    Spieser B, Spratling L (1990) Intermediate dose rate remote afterloading brachytherapy for intraluminal control of bronchogenic carcinoma. Int J Radiat Oncol Biol Phys 18: 1443–1448CrossRefGoogle Scholar
  125. 63.
    McDonald AD, McDonald JC (1987) Epidemiology of malignant mesothelioma. In: Antman K, Aisner J (eds) Asbestos-related malignancy. Grune and Stratton, OrlandoGoogle Scholar
  126. 64.
    Walker AM, Loughlin JE, Freidlander ER et al (1983) Projections of asbestos-related disease, 1980–2009. J Occup Med 25: 409–425PubMedGoogle Scholar
  127. 65.
    Hogan MD, Hoel DG (1981) Estimated cancer risk associated with occupational asbestos exposure. Risk Anal 1: 67–73CrossRefGoogle Scholar
  128. 66.
    Wagner JC, Slegg CA, Marchand P (1960) Diffuse pleural mesotheliomas and asbestos exposure in Northwestern Cape Province. Br J Med 17: 260–271Google Scholar
  129. 67.
    Women inspectors of factories (1989) Annual Report for 1988. Her Majesty’s Stationery Office, LondonGoogle Scholar
  130. 68.
    Mossman BT, Gee JBL (1989) Asbestos-related diseases. N Engl J Med 320: 1721–1730PubMedCrossRefGoogle Scholar
  131. 69.
    Wagner JC (1986) Mesothelioma and mineral fibers. Cancer 57: 1905–1911PubMedCrossRefGoogle Scholar
  132. 70.
    Huncharek M (1992) Changing risk groups for malignant mesothelioma. Cancer 69: 2704–2711PubMedCrossRefGoogle Scholar
  133. 71.
    Huncharek M (1994) Asbestos and cancer: epidemiological and public health controversies. Cancer Invest 12: 214–222PubMedCrossRefGoogle Scholar
  134. 72.
    Connelly RR, Spirtas R, Myers MH et al (1987) Demographic patterns for mesothelioma in the United States. J Natl Cancer Inst 78: 1053–1060PubMedGoogle Scholar
  135. 73.
    Antman KH, Pass HI (1997) Benign and malignant mesothelioma. In: DevVita VT Jr, Hellman S, Rosenberg SA (eds) Cancer, principles and practice of oncology, 5th edn. Lippincott-Raven, Philadelphia, pp 1853–1878Google Scholar
  136. 74.
    Donna A, Betta PG (1981) Mesotheliomas: a new embryological approach to primary tumors of coelomic surfaces. Histopathology 5: 31–44PubMedCrossRefGoogle Scholar
  137. 75.
    Gibbs AR, Harsch R, Wagner JC, Jasani B (1985) Comparison of tumor markers in malignant mesothelioma and pulmonary adenocarcinoma. Thorax 40: 91–95PubMedCrossRefGoogle Scholar
  138. 76.
    Boutin C, Rey F, Gouvernet J et al (1993) Thoracoscopy in pleural malignant mesothelioma: a prospective study of 188 patients, part 2. Prognosis and staging. Cancer 73: 394–404Google Scholar
  139. 77.
    Antman KH, Shemin R, Ryan L et al (1988) Malignant mesothelioma: prognostic variables in a registry of 180 patients, The Dana Farber Cancer Institute and Brigham and Women’s Hospital experience over two decades, 1965–1985. J Clin Oncol 6: 147–153PubMedGoogle Scholar
  140. 78.
    Rusch VW, Figlin R (2001) Pleural mesothelioma. In: Hjaskell CM (ed) Cancer Treatment, 5th ed. Saunders, Philadelphia, pp 639–645Google Scholar
  141. 79.
    Boutin C, Rey F, Gouvernet J et al (1993) Thoracoscopy in pleural malignant mesothelioma: a prospective study of 188 patients, part 1. Diagnosis. Cancer 72: 389–393Google Scholar
  142. 80.
    American Joint Committee on Cancer (1998) AJCC Cancer Staging Handbook. Pleural mesothelioma. Lippincott-Raven, Philadelphia, pp 129–131Google Scholar
  143. 81.
    Butchart EG, Ashcroft T, Barnsely WC, Holden MP (1981) The role of surgery in diffuse malignant mesothelioma of the pleura. Semin Oncol 8: 321–328PubMedGoogle Scholar
  144. 82.
    DaVAlle MJ, Faber LP, Kittle CF (1986) Extrapleural pneumonectomy for diffuse malignant mesothelioma. Ann Thorac Surg 42: 612–618PubMedCrossRefGoogle Scholar
  145. 83.
    Sugarbaker DJ, Strauss GM, Lynch TJ et al (1993) Node status has prognostic significance in the multimodality therapy of diffuse, malignant mesothelioma. J Clin Oncol 11: 1172–1178PubMedGoogle Scholar
  146. 84.
    Allen KB, Faber LP, Warren WH (1994) Malignant pleural mesothelioma: extrapleural pneumonectomy and pleurectomy. Chest Surg Clin North Am 4: 113–126Google Scholar
  147. 85.
    Burchart EG (1989) Surgery of mesothelioma of the pleura. In: Roth JH, Ruckdeschel JC, Weseinberger TH (eds) Thoracic oncology. Saunders, Philadelphia, pp 566–583Google Scholar
  148. 86.
    Wanebo HJ, Martini N, Melamed MR et al (1976) Pleural mesothelioma. Cancer 38: 2481–2488PubMedCrossRefGoogle Scholar
  149. 87.
    Carmichael J, Degraff WG, Gamson J et al (1989) Radiation sensitivity of human lung cancer cell lines. Eur J Cancer Clin Oncol 25: 527–534PubMedCrossRefGoogle Scholar
  150. 88.
    Rusch V, Saltz L, Venkatraman E et al (1994) A phase II trial of pleurectomy/decortication followed by intrapleural and systemic chemotherapy for malignant pleural mesothelioma. J Clin Oncol 12: 1156–1163PubMedGoogle Scholar
  151. 89.
    Ruffle P, Fels R, Minkin S et al (1989) Diffuse malignant mesothelioma of the pleura in Ontario and Quebec: a retrospective study of 332 patients. J Clin Oncol 7: 1157–1168Google Scholar
  152. 90.
    Gordon W, Antman KH, Breenberger J et al (1982) Radiation therapy in the management of patients with mesothelioma. Int J Radiat Oncol Biol Phys 8: 19–25PubMedCrossRefGoogle Scholar
  153. 91.
    De Graaf-Strukowska L, van der Zee J, van Putten W, Senan S (1999) Factors influencing the outcome of radiotherapy in malignant mesothelioma of the pleura–a single institution experience with 189 patients. Int J Radiat Oncol Biol Phys 43: 511–516PubMedCrossRefGoogle Scholar
  154. 92.
    Boutin C, Rey V, Vaillat J-R (1995) Prevention of malignant seeding after invasive diagnostic procedures in patients with pleural mesothelioma: a randomized trial of local radiotherapy. Chest 108: 754–758PubMedCrossRefGoogle Scholar
  155. 93.
    Maasilta P (1991) Deterioration in lung function following hemithorax irradiation for pleural mesothelioma. Int J Radiat Oncol Biol Phys 20: 433–438PubMedCrossRefGoogle Scholar
  156. 94.
    Mattson K, Holsti LR, Tammilehto L et al (1992) Multimodality treatment programs for malignant pleural mesothelioma using high-dose hemithorax irradiation. Int J Radiat Oncol Biol Phys 24: 643–650PubMedCrossRefGoogle Scholar
  157. 95.
    Hilaris BS, Dattatreyudu N, Kwong E et al (1984) Pleurectomy and intraoperative brachytherapy and postoperative radiation in the management of malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys 10: 325–331PubMedCrossRefGoogle Scholar
  158. 96.
    Kutcher GJ, Kestler C, Greenblatt D et al (1987) Technique for external beam treatment for mesothelioma. Int J Radiat Oncol Biol Phys 13: 1747–1752PubMedCrossRefGoogle Scholar
  159. 97.
    Herscher LL, Hahn SM, Kroog G et al (1998) Phase I study of paclitaxel as a radiation sensitizer in the treatment of mesothelioma and non-small cell lung cancer. J Clin Oncol 16: 635–641PubMedGoogle Scholar
  160. 98.
    Law MR, Gregor A, Hodson ME et al (1984) Malignant mesothelioma of the pleura: a study of 52 treated and 64 untreated patients. Thorax 39: 255–259PubMedCrossRefGoogle Scholar
  161. 99.
    Brenner J, Sordillo PP, Magill GB, Golbey RB (1982) Malignant mesothelioma of the pleura. Review of 123 patients. Cancer 49: 2431–2435PubMedCrossRefGoogle Scholar
  162. 100.
    Tion Ong S, Vogelzang N (1996) Chemotherapy in malignant pleural mesothelioma: a review. J Clin Oncol 14: 1007–1017Google Scholar
  163. 101.
    Krarup-Hansen A, Hansen HH (1991) Chemotherapy in malignant mesothelioma: a review. Cancer Chemother Pharmacol 28: 319–330PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2003

Authors and Affiliations

  • Robert G. Parker
    • 1
  • Nora A. Janjan
    • 2
  • Michael T. Selch
    • 1
  1. 1.Department of Radiation Oncology, UCLA School of MedicineUniversity of California, Los AngelesLos AngelesUSA
  2. 2.Department of Radiation OncologyM.D. Anderson Cancer CenterHoustonUSA

Personalised recommendations